Rheumatic Diseases Terminated Phase 3 Trials for Cyclobenzaprine (DB00924)

Also known as: Rheumatic Disease / Rheumatism, unspecified / Rheumatics / Rheumatism (disorder) / Rheumatism

IndicationStatusPhase
DBCOND0027857 (Rheumatic Diseases)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02829814Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With FibromyalgiaTreatment